10 things you should know about the new malaria vaccine

Earlier on, news broke about the all-new malaria vaccinewhich has been approved for use in Africa.

The vaccine, Mosquirix, has been 30 years in the making and was developed by pharmaceutical giant,  GlaxoSmithKline.

The European Medicines Agency gave a positive scientific opinion after assessing the vaccine's safety and effectiveness, and in October, the Word Health Organisation will decide whether it should be deployed.

Here are 10 things you should know about the new malaria vaccine.